Chemoresponse after non-curative gastrectomy for M1 gastric cancer

BACKGROUND: M1 gastric cancer has a poor oncologic outcome with a median survival of less than 1 year despite aggressive chemotherapy. Recent trials include chemotherapy combined non-curative gastrectomy. This study evaluated the chemoresponse after non-curative gastrectomy in M1 gastric cancer and...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Hyun Beak, Lee, Seung Hyoung, Son, Young Gil, Ryu, Seung Wan, Sohn, Soo Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4327950/
https://www.ncbi.nlm.nih.gov/pubmed/25634223
http://dx.doi.org/10.1186/s12957-015-0447-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4327950/
https://www.ncbi.nlm.nih.gov/pubmed/25634223
http://dx.doi.org/10.1186/s12957-015-0447-3

Ejemplares similares